BERG, a clinical-stage biotech that employs artificial intelligence to investigate diseases and develop innovative treatments, has announced a new collaborative model across the healthcare industry to fast track drug discovery research for COVID-19 and beyond.
Oak Ridge National Laboratory is one of BERG’s partners that also includes Bristol Myers-Squibb and AdventHealth. The effort is focused on identifying new ways of working and breaking down existing siloes to maximize time and efficiency in identifying and bringing new treatment options to market.
Click here to learn more.